We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$65.3M
Cap. Flow
+$17.1M
Cap. Flow %
3.89%
Top 10 Hldgs %
48.81%
Holding
93
New
22
Increased
21
Reduced
16
Closed
33
Avg Time Held Equity + Options
0.3 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.3 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.2 years

Sector Composition

Rank Sector Weight
1 Healthcare 35.6%
2 Communication Services 13.84%
3 Real Estate 10.92%
4 Energy 8.35%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$35.2M 7.99%
+662,798
New +$33.8M
2013 Q4
0 quarters
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.22T
$26.8M 6.09%
+961,751
New +$24.3M
2013 Q4
0 quarters
HOT
3
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$25.4M 5.77%
319,810
-9,363
-3% -$685K
2013 Q2
2 quarters
GILD icon
4
Gilead Sciences
GILD
$195B
$23.9M 5.42%
318,246
-137,236
-30% -$9.56M
2013 Q2
2 quarters
AMZN icon
5
Amazon
AMZN
$2.75T
$21M 4.78%
1,055,660
+589,220
+126% +$10.6M
2013 Q2
2 quarters
A icon
6
Agilent Technologies
A
$49.5B
$20.4M 4.63%
498,791
+52,791
+12% +$2.01M
2013 Q2
2 quarters
AGN
7
DELISTED
Allergan plc
AGN
$17.5M 3.98%
104,342
+102,294
+4,995% +$16M
2013 Q2
2 quarters
PCP
8
DELISTED
PRECISION CASTPARTS CORP
PCP
$16.2M 3.67%
60,043
+35,977
+149% +$9.05M
2013 Q3
1 quarter
HCA icon
9
HCA Healthcare
HCA
$101B
$14.5M 3.3%
304,646
+73,673
+32% +$3.4M
2013 Q2
2 quarters
MDVN
10
DELISTED
MEDIVATION, INC.
MDVN
$14M 3.19%
439,962
+329,992
+300% +$9.97M
2013 Q2
2 quarters
TNL icon
11
Travel + Leisure Co
TNL
$4B
$13.8M 3.14%
415,928
-247,185
-37% -$7.56M
2013 Q2
2 quarters
ETN icon
12
Eaton
ETN
$156B
$12.6M 2.86%
165,504
-95,205
-37% -$6.77M
2013 Q2
2 quarters
VLO icon
13
Valero Energy
VLO
$128B
$12.3M 2.78%
+243,148
New +$10.2M
2013 Q4
0 quarters
AMT icon
14
American Tower
AMT
$84.5B
$12.1M 2.75%
151,859
+29,556
+24% +$2.3M
2013 Q3
1 quarter
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
$12.1M 2.74%
200,617
+47,611
+31% +$2.59M
2013 Q2
2 quarters
ANDV
16
DELISTED
Andeavor
ANDV
$12M 2.72%
+204,839
New +$10.7M
2013 Q4
0 quarters
META icon
17
Meta Platforms (Facebook)
META
$1.88T
$11.4M 2.58%
+208,343
New +$10.5M
2013 Q4
0 quarters
ADBE icon
18
Adobe
ADBE
$97.9B
$11.3M 2.57%
189,066
-22,721
-11% -$1.26M
2013 Q3
1 quarter
CCI icon
19
Crown Castle
CCI
$34B
$10.6M 2.41%
+144,357
New +$10.7M
2013 Q4
0 quarters
CRM icon
20
Salesforce
CRM
$203B
$9.95M 2.26%
180,207
+408
+0.2% +$21.8K
2013 Q2
2 quarters
TWX
21
DELISTED
Time Warner Inc
TWX
$8.24M 1.87%
123,213
-102,500
-45% -$6.63M
2013 Q2
2 quarters
DG icon
22
Dollar General
DG
$29.5B
$8.04M 1.82%
133,245
-184,552
-58% -$10.8M
2013 Q2
2 quarters
CMI icon
23
Cummins
CMI
$73.3B
$7.52M 1.71%
53,361
-77,717
-59% -$10.3M
2013 Q2
2 quarters
CME icon
24
CME Group
CME
$104B
$7.26M 1.65%
+92,475
New +$7.24M
2013 Q4
0 quarters
ENDP
25
DELISTED
Endo International plc
ENDP
$6.98M 1.58%
+103,467
New +$5.9M
2013 Q4
0 quarters

Similar funds

Partner Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Partner Investment Management held 93 positions worth $441M, up 17% from $375M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Partner Investment Management deployed $17.1M of net new capital in Q4 2013, opening 22 new positions and adding to 21 existing holdings. Its largest new stake was Bristol-Myers Squibb: 662,798 shares worth $35.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 29% a quarter earlier, followed by Communication Services and Real Estate.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $16.1M trimmed.

  • Partner Investment Management's largest Q4 2013 buy was Bristol-Myers Squibb: 662,798 shares worth $35.2M.
  • Partner Investment Management added most to Allergan plc in Q4 2013, an estimated $16M increase.
  • Partner Investment Management's biggest Q4 2013 reduction was Thermo Fisher Scientific, cutting an estimated $16.1M.
  • Partner Investment Management fully exited CAMERON INTERNATIONAL CORPORATION in Q4 2013, selling an estimated $11M.
  • Partner Investment Management's ten largest holdings make up 49% of its $441M portfolio in Q4 2013.
  • Partner Investment Management opened 22 new positions and closed 33 in Q4 2013.
  • Partner Investment Management's portfolio value rose 17% quarter-over-quarter to $441M.

Based on Partner Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.